Effective Arts Education for All” is our battle cry to help end violence against mankind and Mother Earth.  International Arts Education Week on the last week of May is an approved United Nations ...

LYME DISEASE AWARENESS, May 29 at 6 p.m., Trafalgar library, 424 S. Tower Drive. Free and open to the public. A ...

Discover a home of splendor and architectural authenticity, a true Tuscan farmhouse nestled in the waterfront community of ...

Most people say they want to know their risk for Alzheimer's dementia, fewer follow through Among reasons for declining, research participants say knowing would be a burden to themselves, family ...

Get Instant Summarized Text (Gist) Analysis of large health databases indicates that patients taking nucleoside reverse transcriptase inhibitors (NRTIs), drugs used for HIV and hepatitis B, have a ...

You can reach Adam on Signal at stataf.54. The Food and Drug Administration approved on Friday the first blood test for diagnosing Alzheimer’s disease, opening up a quicker way for patients to ...

A team of researchers has developed a vaccine targeting the tau protein, associated with Alzheimer's disease, showing robust immune responses in mice and non-human primates. Encouraged by these ...

The FDA cleared the first blood-based in vitro diagnostic test for Alzheimer's disease, the agency announced Friday. The blood test, known as the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET scans.

Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer's disease by measuring proteins linked to the condition. The new test ...

WASHINGTON (AFP) — The United States on Friday approved the first blood test for Alzheimer’s, a move that could help patients begin treatment earlier with newly approved drugs that slow the ...

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe. UVA Health scientists are calling for clinical trials testing the ...